Compare Sanofi SA (SNY) vs Warner Music Group Corp (WMG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sanofi SA vs Warner Music Group Corp — how do they compare? Sanofi SA trades at $40.07 (market cap $95.18B), while Warner Music Group Corp trades at $28.72 (market cap $15.12B). The key difference: Sanofi SA is far larger — about 6.3× Warner Music Group Corp's market cap, and Sanofi SA pays the higher dividend (6.01%). Which is the better fit depends on your goals — on Pluang, investors hold Sanofi SA for 94 Days and Warner Music Group Corp for 96 Days on average.
| SNY | WMG | |
|---|---|---|
Market Cap | $95.18B | $15.12B |
Volume | 2,995,646 | 2,966,414 |
Sector | Health | Media |
52-Week High | $52.34 | $34.72 |
52-Week Low | $39.51 | $23.65 |
Typical Hold Time | 94 Days | 96 Days |
Enterprise Value | $114.48B | $19.42B |
Dividend Yield | 6.01% | 2.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Sanofi (SNY) trades at $40.23, showing minimal daily movement with a 0.07% gain. The stock presents mixed signals with bearish technical indicators but strong fundamental performance, including three consecutive quarterly earnings beats. Recent expansion of the immunology alliance with Regeneron through an $8 billion deal highlights strategic growth initiatives. Valuation metrics show a P/E of 22.14 and P/S of 1.77, while profitability remains solid with a 72.77% gross margin.
SNY offers steady growth potential driven by pipeline expansion and Dupixent momentum, though patent expiration risks loom. Analyst sentiment is cautiously optimistic with 44% buy ratings, but technical weakness and projected 2026 earnings decline present near-term headwinds. The stock represents a balanced opportunity for long-term investors seeking pharmaceutical exposure with manageable risk.
Warner Music Group (WMG) trades at $28.91, up 2.66% with strong technical momentum and bullish moving average signals. The company reported solid Q2 2026 earnings, beating EPS estimates with $0.38 vs. $0.34 expected, while revenue growth continues with 2026 projections showing $7.3B. Recent AI partnerships with Suno and NetEase Cloud Music highlight strategic positioning in the evolving music industry landscape.
WMG presents a compelling investment case with 66.7% analyst buy ratings and a $39.50 consensus price target representing 36.6% upside. However, risks include recent CFO departure, ongoing AI copyright litigation, and margin pressure from 2025's 5.44% net margin. The stock's premium valuation at 23.12 P/E requires continued execution on streaming growth and AI initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →About Warner Music Group Corp
Warner Music Group is the third largest of the three major global record labels, with Vivendi's Universal Music in first and Sony Music in second. Warner's larger segment, recorded music, consists of iconic labels like Atlantic Records, Warner Records, and Parlophone Records and popular artists such as Ed Sheeran, Cardi B, Dua Lipa, and Blake Shelton. Warner Chappell, the firm's publishing arm, is the home to over 65,000 composers and songwriters with over a million copyrights represented. Warner is controlled by Access Industries, which owns an 84% economic interest and 99% of voting rights.
Read more on WMG →
